MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » BioTrace Medical touts real-world data from Tempo temporary lead

BioTrace Medical touts real-world data from Tempo temporary lead

By

BioTrace

BioTrace Medical today released data from real-world experiences with its Tempo temporary pacing lead, touting no dislodgements or perforations and reliable pace capture during and after the procedure.

The real-world experiences as well as 2 live cases were presented during the Transcatheter Valve Therapies 2017 in Chicago this week.

In a presentation, Dr. Tamim Nazif of the NewYork-Presbyterian/Columbia University Medical Center released data from real-world experiences, including 3 cases from their Medical Center and several hundred other cases which reported no device-related adverse events, no perforations and dislodgements and an overall highly favorable operator feedback.

“Our real-world experience with the Tempo Lead is consistent with the excellent results of the New Zealand first-in-human study demonstrating the safety and reliable performance of the device. The Tempo Lead may improve the safety of TAVR and other structural heart procedures by reducing complications like cardiac perforation, loss of pacing capture, and valve embolization. There may also be opportunities with the Tempo Lead to reduce the length of ICU stay, expedite recovery, and reduce permanent pacemaker implantation with a strategy of watchful waiting in patients with transient conduction disturbances,” Dr. Nazif said in a prepared release.

Results from a separate multi-center study of 25 patients demonstrated no device related adverse evetns, dislogements and sustained ventricular arrhythmia or cardiac perforations. Rapid pacing was recorded as successful with no loss of capture, the company said.

“The Tempo Lead has become an important part of our TAVR practice, and I believe that due to its stability and safety the use of this innovative technology will become an important adjunct for TAVR procedures. Our own experience to date has been consistent with clinical data from the first-in-human study of the device. This technology provides peace of mind, offering stable pacing both during and after the procedure,” Dr. Susheel Kodali of the NewYork-Presbyterian/Columbia University Medical Center said in a prepared statement.

“The clinical community has been highly supportive of the use of the Tempo Lead. We are excited that many top TAVR centers recognize the Tempo Lead’s value, making it their lead of choice for TAVR procedures,” BioTrace prez & CEO Laura Dietch said in a prepared statement.

In case you missed it

RSS From Medical Design & Outsourcing

  • Integrated Computer Solutions, Variscite to collaborate on hardware and software solution
    Integrated Computer Solutions (ICS) and Variscite announced today that they are collaborating on new solutions in the embedded market. The collaboration aims to offer a complete hardware and software solution to customers in the market, with Variscite’s SoM (system on module) solutions and ICS’ best-in-class software services set to provide a complete system solution that… […]
  • Veranex acquires medtech design firm Worrell
    Veranex today announced that it has acquired medtech design firm Worrell for an undisclosed amount. Raleigh, N.C.-based Veranex delivers strategic, operations and financial benefits to medical device companies and engineers that are developing breakthrough technologies, according to the company. The acquisition of Worrell will expand its offerings and geographic reach. “The addition of Worrell strengthens… […]
  • Movia Robotics launches TheraPal digital health aide for neurodiverse individuals
    Movia Robotics this week announced that it has launched its TheraPal line of digital health aides for autism spectrum disorder and other intellectual or developmental disabilities. Bristol, Connecticut-based Movia Robotics released its TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical assist aides for use in homes and clinician offices. The robotic aides are designed to… […]
  • Instron launches Bluehill Central lab management software
    Instron announced today that it launched the Bluehill Central lab management solution for Bluehill Universal software. Norwood, Massachusetts-based Instron’s Bluehill Central platform allows lab managers to remotely manage all test systems running Bluehill Universal, regardless of the number of systems and regardless of their location around the world, according to a news release. The company… […]
  • Lenovo, LG to collaborate on radiology technology
    Lenovo and LG announced today that they are collaborating on new medical imaging solutions to aid the radiology community. According to a news release, the companies will work together to bundle LG’s high-performance medical monitors with the Lenovo original equipment manufacturer (OEM) solutions commercial third-party portfolio of offerings. Get the full story at our sister… […]
  • Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list
    Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of the largest public corporations around. Companies were judged with… […]
  • HHS reports 63-fold increase in telehealth use during pandemic
    A new study from the U.S. Department of Health and Human Services found a 63-fold increase in Medicare telehealth use during the COVID-19 pandemic. The report analyzed Medicare fee-for-service data from 2019 and 2020 and highlighted that people in urban areas were more likely to seek and use telehealth services than rural residents. In addition,… […]
  • Carlyle makes a significant investment in Resonetics
    Carlyle-managed funds have acquired a significant interest in medical device contract manufacturer Resonetics. Today’s announcement did not include the investment size, but the deal values Nashua, New Hampshire–based Resonetics at roughly  $2.25 billion. Carlyle joins existing investor GTCR as a meaningful shareholder in the company. Resonetics focuses on producing highly technical components for medical device… […]
  • Interpreting Pump Performance Curves
    Reading pump performance curves is crucial to proper pump selection. This piece reviews the creation and use of diaphragm pump performance curves to determine flow at given vacuum or pressure conditions. Included is a lesser-known method to interpolate pump performance when flow restrictions exist on both the inlet and outlet sides of the pump. Download… […]
  • BD elaborates on diversity and equity goals
    BD (NYSE:BDX) earlier this week outlined its efforts this year related to global inclusion, diversity and equity. Franklin Lakes, New Jersey-based BD released its 2021 Global Inclusion, Diversity and Equity (ID&E) Report, highlighting the progress it’s made in human health as part of its environmental, social and governance (ESG) strategy, according to a news release.… […]
  • How to protect medical devices from hidden cybersecurity risks
    Your software supply chain could be a cybersecurity risk. Here’s what you can do. Vince Arneja, GrammaTech The healthcare industry has been fighting a war on two fronts during the COVID-19 pandemic against the virus and an outbreak of cyberattacks. The Department of Health and Human Services says the sector reported a 9,851% increase in… […]